Shownotes
In this episode, Jim Zeliff, DVM, MBA, AAEP representative to the AVMA Legislative Advisory Council, provided an update on xylazine regulations and explained what veterinarians should expect when it becomes a scheduled drug in the near future.
The Business of Practice podcast is brought to you by CareCredit.
This information is shared solely for your convenience. You are urged to consult with your individual advisors with respect to any information presented.
Business of Practice Podcast Hosts, Guests, and Links Episode 96: